Since the discovery of the relationship of NT-proBNP and cardiac function [25], an increasing body of evidence has proved the usefulness of this biomarker for diagnosis, risk stratification, and monitoring in HF patients [26,27]. Here, NPPB is linked to hydrops fetalis.